» Articles » PMID: 26839879

Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2016 Feb 4
PMID 26839879
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The Community Pharmacy of the Department of Ambulatory Care and Community Medicine (Policlinique Médicale Universitaire, PMU), University of Lausanne, developed and implemented an interdisciplinary medication adherence program. The program aims to support and reinforce medication adherence through a multifactorial and interdisciplinary intervention. Motivational interviewing is combined with medication adherence electronic monitors (MEMS, Aardex MWV) and a report to patient, physician, nurse, and other pharmacists. This program has become a routine activity and was extended for use with all chronic diseases. From 2004 to 2014, there were 819 patient inclusions, and 268 patients were in follow-up in 2014. This paper aims to present the organization and program's context, statistical data, published research, and future perspectives.

Citing Articles

The impact of interprofessional collaboration between pharmacists and community health workers on medication adherence: a systematic review.

Bandiera C, Ng R, Mistry S, Harris E, Harris M, Aslani P Int J Equity Health. 2025; 24(1):58.

PMID: 40022158 PMC: 11869407. DOI: 10.1186/s12939-025-02415-4.


A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial.

Bandiera C, Cardoso E, Locatelli I, Zaman K, Diciolla A, Digklia A PLoS One. 2024; 19(6):e0304573.

PMID: 38848380 PMC: 11161104. DOI: 10.1371/journal.pone.0304573.


The differential impact of a 6- 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.

Bandiera C, Dotta-Celio J, Locatelli I, Nobre D, Wuerzner G, Pruijm M Front Pharmacol. 2024; 15:1294436.

PMID: 38327981 PMC: 10847300. DOI: 10.3389/fphar.2024.1294436.


Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care.

Bawab N, Moullin J, Jotterand S, Rossier C, Schneider M, Perraudin C J Contin Educ Health Prof. 2023; 43(2):77-86.

PMID: 36877813 PMC: 10219666. DOI: 10.1097/CEH.0000000000000466.


Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.

Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A Cancers (Basel). 2023; 15(1).

PMID: 36612312 PMC: 9818079. DOI: 10.3390/cancers15010316.


References
1.
Krummenacher I, Cavassini M, Bugnon O, Schneider M . Characteristics of HIV patients referred to a medication adherence program in Switzerland. Int J Clin Pharm. 2012; 34(3):426-31. DOI: 10.1007/s11096-012-9638-y. View

2.
Krummenacher I, Spencer B, Du Pasquier S, Bugnon O, Cavassini M, Schneider M . Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme. Int J Clin Pharm. 2014; 36(4):716-24. DOI: 10.1007/s11096-014-9930-0. View

3.
Guignard E, Bugnon O . Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother. 2006; 40(3):512-7. DOI: 10.1345/aph.1G199. View

4.
Drotar D . Strategies of adherence promotion in the management of pediatric chronic conditions. J Dev Behav Pediatr. 2013; 34(9):716-29. DOI: 10.1097/DBP.0b013e31829f6781. View

5.
Fisher J, Fisher W, Amico K, Harman J . An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006; 25(4):462-73. DOI: 10.1037/0278-6133.25.4.462. View